13.17
price up icon5.78%   0.72
after-market Handel nachbörslich: 13.24 0.07 +0.53%
loading

Adaptive Biotechnologies Corp Aktie (ADPT) Neueste Nachrichten

pulisher
11:20 AM

Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap UpWhat's Next? - MarketBeat

11:20 AM
pulisher
Mar 12, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Down 9.9%Here's Why - MarketBeat

Mar 12, 2026
pulisher
Mar 10, 2026

Piper Sandler reiterates Adeptus Biotechnologies stock rating at overweight By Investing.com - Investing.com India

Mar 10, 2026
pulisher
Mar 10, 2026

Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells 19,460 Shares of Stock - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

[144] Adaptive Biotechnologies Corp SEC Filing - Stock Titan

Mar 10, 2026
pulisher
Mar 10, 2026

Piper Sandler reiterates Adeptus Biotechnologies stock rating at overweight - Investing.com

Mar 10, 2026
pulisher
Mar 09, 2026

Lo Francis, chief people officer at Adaptive Biotechnologies, sells $574k in ADPT By Investing.com - Investing.com South Africa

Mar 09, 2026
pulisher
Mar 09, 2026

Lo Francis, chief people officer at Adaptive Biotechnologies, sells $574k in ADPT - Investing.com Nigeria

Mar 09, 2026
pulisher
Mar 09, 2026

Adaptive Biotechnologies (ADPT) HR chief offloads shares to cover RSU taxes - Stock Titan

Mar 09, 2026
pulisher
Mar 08, 2026

Do Insider Sales Align With Adaptive Biotechnologies' (ADPT) MRD-Driven Momentum and Long-Term Strategy? - simplywall.st

Mar 08, 2026
pulisher
Mar 07, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) Stock Rating Lowered by Wall Street Zen - MarketBeat

Mar 07, 2026
pulisher
Mar 06, 2026

Loss Report: Will Adaptive Biotechnologies Corporation stock go up in YEAR - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Insider Sales Put Focus On Adaptive Biotechnologies Growth Story And Dilution Risk - Yahoo Finance

Mar 06, 2026
pulisher
Mar 05, 2026

Adaptive Biotechnologies’ Rubinstein sells $1.49m in shares By Investing.com - Investing.com UK

Mar 05, 2026
pulisher
Mar 05, 2026

Adaptive Biotechnologies’ Rubinstein sells $1.49m in shares - Investing.com Nigeria

Mar 05, 2026
pulisher
Mar 05, 2026

Adaptive Biotechnologies Corp. Achieves 102.46% Yearly Gain, Establishing It as a Multibagger Stock - Markets Mojo

Mar 05, 2026
pulisher
Mar 05, 2026

Amova Asset Management Americas Inc. Decreases Stake in Adaptive Biotechnologies Corporation $ADPT - MarketBeat

Mar 05, 2026
pulisher
Mar 04, 2026

Insider Sell: Harlan Robins Sells 24,233 Shares of Adaptive Biot - GuruFocus

Mar 04, 2026
pulisher
Mar 04, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) Insider Harlan Robins Sells 10,000 Shares - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Adaptive Biotechnologies CSO Robins sells $392,329 in ADPT stock By Investing.com - Investing.com Australia

Mar 04, 2026
pulisher
Mar 04, 2026

Adaptive Biotechnologies CSO Robins sells $392,329 in ADPT stock - Investing.com

Mar 04, 2026
pulisher
Mar 03, 2026

Chad Robins Sells 289,024 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) CEO Sells $823,848.16 in Stock - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

Insider Sell: Chad Robins Sells 524,998 Shares of Adaptive Biote - GuruFocus

Mar 03, 2026
pulisher
Mar 03, 2026

CEO of Adaptive Biotechnologies (NASDAQ: ADPT) sells 524,998 shares - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Adaptive Biotechnologies CEO Sells Over $8 Million in Company Stock - TradingView

Mar 03, 2026
pulisher
Mar 03, 2026

A Look At Adaptive Biotechnologies (ADPT) Valuation As CEO Updates MRD Growth And Profitability Outlook - simplywall.st

Mar 03, 2026
pulisher
Mar 03, 2026

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: Unveiling a 29% Upside Potential for Savvy Investors - DirectorsTalk Interviews

Mar 03, 2026
pulisher
Mar 02, 2026

Adaptive Biotechnologies CEO Flags MRD Momentum, Lifts 2025 Volume Outlook to 30%+ at TD Cowen Conf. - Yahoo Finance

Mar 02, 2026
pulisher
Mar 02, 2026

Adaptive Biotechnologies at TD Cowen Conference: Strategic Growth Insights - Investing.com

Mar 02, 2026
pulisher
Mar 02, 2026

Chad Robins files Form 144 to sell ADPT shares (ADPT) - Stock Titan

Mar 02, 2026
pulisher
Mar 01, 2026

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Mar 01, 2026
pulisher
Mar 01, 2026

Adaptive Biotechnologies2026 Funding Rounds & List of Investors - Tracxn

Mar 01, 2026
pulisher
Feb 28, 2026

Why are Analysts Optimistic About Adaptive Biotechnologies (ADPT)? - Yahoo Finance

Feb 28, 2026
pulisher
Feb 27, 2026

Chad M. Robins files multiple Rule 144 notices for ADPT (ADPT) - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

Decoding Adaptive Biotechnologies Corp (ADPT): A Strategic SWOT Insight - GuruFocus

Feb 27, 2026
pulisher
Feb 26, 2026

Adaptive Biotechnologies (NASDAQ: ADPT) posts 2025 MRD-driven surge - Stock Titan

Feb 26, 2026
pulisher
Feb 26, 2026

Does Post‑Earnings Analyst Optimism Around clonoSEQ Adoption Change The Bull Case For Adaptive (ADPT)? - simplywall.st

Feb 26, 2026
pulisher
Feb 21, 2026

TD Cowen is Bullish on Adaptive Biotechnologies Corporation (ADPT) - Finviz

Feb 21, 2026
pulisher
Feb 20, 2026

ADPT Technical Analysis & ETF Price Forecast - Intellectia AI

Feb 20, 2026
pulisher
Feb 13, 2026

Principal Financial Group Inc. Sells 303,285 Shares of Adaptive Biotechnologies Corporation $ADPT - MarketBeat

Feb 13, 2026
pulisher
Feb 11, 2026

Buy Signal: What is the earnings history of EUDAW2025 Technical Overview & Free Community Consensus Stock Picks - baoquankhu1.vn

Feb 11, 2026
pulisher
Feb 11, 2026

Allianz Asset Management GmbH Raises Stock Holdings in Adaptive Biotechnologies Corporation $ADPT - MarketBeat

Feb 11, 2026
pulisher
Feb 08, 2026

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year - Yahoo Finance

Feb 08, 2026
pulisher
Feb 08, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Feb 08, 2026
pulisher
Feb 06, 2026

Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) CFO Sells 2,145 Shares of Stock - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

ADPT: BTIG Raises Price Target Following Analyst Update | ADPT S - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $21.00 - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

ADPT: JP Morgan Raises Price Target and Maintains Overweight Rat - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

Adaptive Biotechnologies (ADPT) stock swings after earnings as MRD guidance, insider sale draw scrutiny - TechStock²

Feb 06, 2026
pulisher
Feb 06, 2026

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 06, 2026
pulisher
Feb 06, 2026

Adeptus Biotechnologies stock price target raised to $22 by BTIG on strong MRD growth By Investing.com - Investing.com Nigeria

Feb 06, 2026
pulisher
Feb 06, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up on Better-Than-Expected Earnings - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

Adeptus Biotechnologies stock price target raised to $22 by BTIG on strong MRD growth - Investing.com UK

Feb 06, 2026
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):